Enhanced Risk of Type 2 Diabetes Mellitus following treatment with 5a-Reductase Inhibitors - Edinburgh Research Explorer

Edinburgh Research Explorer

Enhanced Risk of Type 2 Diabetes Mellitus following treatment with 5a-Reductase Inhibitors

Project: Research

Andrew, Ruth (Principal Investigator)
Walker, Brian (Co-investigator)

Status	Finished
Effective start/end date	1/10/16 → 31/12/17

Total award	£63,270.00
Funding organisation	UK-based charities
Funder project reference	733

Period	1/10/16 → 31/12/17

Research outputs

Data for analysis of catechol estrogen metabolites in human plasma by liquid chromatography tandem mass spectrometry
Research output: Contribution to journal › Article › peer-review
Derivatization enhances analysis of estrogens and their bioactive metabolites in human plasma by liquid chromatography tandem mass spectrometry
Research output: Contribution to journal › Article › peer-review
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
Research output: Contribution to journal › Article › peer-review